Releases - RaySearch Laboratories

• Net sales totaled SEK 29.0m (24.9) between January and September 2004
• Net profit was SEK 11.3m (7.4) during the period
• Earnings per share after tax reached SEK 1.08 (0.70)
• Operating profit totaled SEK 12.9m (11.4)
• Investments in research and development increased by 60 percent
• New products based on the partnership with both Philips which Nucletron have been well received at significant industry...

• Net sales totaled SEK 20.5m (18.5) between January and June 2004
• Net profit was SEK 6.5m (7.2) during the period
• Earnings per share after tax reached SEK 0.62 (0.68)
• Operating profit totaled SEK 9.1m (10.2)
• Major initiatives in research and development
• Leading radiation therapy center in Europe orders 14 systems each of RayOptimizer, RayMachine, and RayBiology
• The partnership with Nucletron is making...

• Net sales totaled SEK 10.1m (7.3) between January and March 2004
• Net profit was SEK 3.9m (2.8) during the period
• Earnings per share after tax reached SEK 0.37 (0.27)
• Operating profit totaled SEK 5.5m (3.9)
• Licensing agreement signed with Nucletron; customer base doubles
• Intensified focus on research and development
For more information, please contact:
Johan Löf
CEO, RaySearch Laboratories AB...